BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Banerjee S, Gupta N, Kodan P, Mittal A, Ray Y, Nischal N, Soneja M, Biswas A, Wig N. Nipah virus disease: A rare and intractable disease. Intractable Rare Dis Res 2019;8:1-8. [PMID: 30881850 DOI: 10.5582/irdr.2018.01130] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Loomis RJ, DiPiazza AT, Falcone S, Ruckwardt TJ, Morabito KM, Abiona OM, Chang LA, Caringal RT, Presnyak V, Narayanan E, Tsybovsky Y, Nair D, Hutchinson GB, Stewart-Jones GBE, Kueltzo LA, Himansu S, Mascola JR, Carfi A, Graham BS. Chimeric Fusion (F) and Attachment (G) Glycoprotein Antigen Delivery by mRNA as a Candidate Nipah Vaccine. Front Immunol 2021;12:772864. [PMID: 34956199 DOI: 10.3389/fimmu.2021.772864] [Reference Citation Analysis]
2 Devnath P, Masud HMAA. Nipah virus: a potential pandemic agent in the context of the current severe acute respiratory syndrome coronavirus 2 pandemic. New Microbes New Infect 2021;41:100873. [PMID: 33758670 DOI: 10.1016/j.nmni.2021.100873] [Reference Citation Analysis]
3 Loomis RJ, Stewart-Jones GBE, Tsybovsky Y, Caringal RT, Morabito KM, McLellan JS, Chamberlain AL, Nugent ST, Hutchinson GB, Kueltzo LA, Mascola JR, Graham BS. Structure-Based Design of Nipah Virus Vaccines: A Generalizable Approach to Paramyxovirus Immunogen Development. Front Immunol 2020;11:842. [PMID: 32595632 DOI: 10.3389/fimmu.2020.00842] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
4 Playford EG, Munro T, Mahler SM, Elliott S, Gerometta M, Hoger KL, Jones ML, Griffin P, Lynch KD, Carroll H, El Saadi D, Gilmour ME, Hughes B, Hughes K, Huang E, de Bakker C, Klein R, Scher MG, Smith IL, Wang LF, Lambert SB, Dimitrov DS, Gray PP, Broder CC. Safety, tolerability, pharmacokinetics, and immunogenicity of a human monoclonal antibody targeting the G glycoprotein of henipaviruses in healthy adults: a first-in-human, randomised, controlled, phase 1 study. Lancet Infect Dis 2020;20:445-54. [PMID: 32027842 DOI: 10.1016/S1473-3099(19)30634-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
5 Leach M, Macgregor H, Ripoll S, Scoones I, Wilkinson A. Rethinking disease preparedness: incertitude and the politics of knowledge. Critical Public Health. [DOI: 10.1080/09581596.2021.1885628] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Kuthyar S, Anthony CL, Fashina T, Yeh S, Shantha JG. World Health Organization High Priority Pathogens: Ophthalmic Disease Findings and Vision Health Perspectives. Pathogens 2021;10:442. [PMID: 33917710 DOI: 10.3390/pathogens10040442] [Reference Citation Analysis]
7 Keiffer TR, Ciancanelli MJ, Edwards MR, Basler CF. Interactions of the Nipah Virus P, V, and W Proteins across the STAT Family of Transcription Factors. mSphere 2020;5:e00449-20. [PMID: 33328346 DOI: 10.1128/mSphere.00449-20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
8 Soman Pillai V, Krishna G, Valiya Veettil M. Nipah Virus: Past Outbreaks and Future Containment. Viruses 2020;12:E465. [PMID: 32325930 DOI: 10.3390/v12040465] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
9 Genzer SC, Welch SR, Scholte FEM, Harmon JR, Coleman-McCray JD, Lo MK, Montgomery JM, Nichol ST, Spiropoulou CF, Spengler JR. Alterations in Blood Chemistry Levels Associated With Nipah Virus Disease in the Syrian Hamster Model. J Infect Dis 2020;221:S454-9. [PMID: 31747016 DOI: 10.1093/infdis/jiz552] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Marques MC, Lousa D, Silva PM, Faustino AF, Soares CM, Santos NC. The Importance of Lipid Conjugation on Anti-Fusion Peptides against Nipah Virus. Biomedicines 2022;10:703. [DOI: 10.3390/biomedicines10030703] [Reference Citation Analysis]